Assessment of Lentiviral Vector Mediated CFTR Correction in Mice Using an Improved Rapid in vivo Nasal Potential Difference Measurement Protocol
Cystic Fibrosis (CF) is caused by a defect in the CF transmembrane conductance regulator (CFTR) gene responsible for epithelial ion transport. Nasal potential difference (PD) measurement is a well established diagnostic technique for assessing the efficacy of therapies in CF patients and animal mode...
Main Authors: | P. Cmielewski, J. Delhove, M. Donnelley, D. Parsons |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.714452/full |
Similar Items
-
Single-Dose Lentiviral Mediated Gene Therapy Recovers CFTR Function in Cystic Fibrosis Knockout Rats
by: Nicole Reyne, et al.
Published: (2021-05-01) -
Breaching the Delivery Barrier: Chemical and Physical Airway Epithelium Disruption Strategies for Enhancing Lentiviral-Mediated Gene Therapy
by: Alexandra McCarron, et al.
Published: (2021-04-01) -
Gene Therapy for Cystic Fibrosis Lung Disease: Overcoming the Barriers to Translation to the Clinic
by: Martin Donnelley, et al.
Published: (2018-11-01) -
Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length
by: Anson Don S, et al.
Published: (2010-06-01) -
Increased CFTR expression and function from an optimized lentiviral vector for cystic fibrosis gene therapy
by: Laura I. Marquez Loza, et al.
Published: (2021-06-01)